speb/financial-data huggingface dataset:
APO balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 1088000000.00
APO income_statement (annual, 2025-12-31) — Average Dilution Earnings: 0.00
APO income_statement (quarterly, 2025-12-31) — Average Dilution Earnings: 0.00
APO income_statement (annual, 2025-12-31) — Basic Average Shares: 589450878.00
APO income_statement (annual, 2025-12-31) — Basic EPS: 5.58
APO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 17112000000.00
APO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 21201000000.00
APO balance_sheet (annual, 2025-12-31) — Capital Stock: 1398000000.00
APO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1398000000.00
APO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 19240000000.00
APO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 19240000000.00
APO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 248060000000.00
APO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 248060000000.00
APO cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -1298000000.00
APO cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -335000000.00
APO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 60200000000.00
APO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 8947000000.00
APO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -63972000000.00
APO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -14218000000.00
APO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 7246000000.00
APO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 4669000000.00
APO cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -367000000.00
APO cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 1154000000.00
APO cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 6568000000.00
APO cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 1051000000.00
APO cash_flow (annual, 2025-12-31) — Change In Working Capital: 6201000000.00
APO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 2205000000.00
APO cash_flow (annual, 2025-12-31) — Changes In Cash: 3474000000.00
APO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -602000000.00
APO balance_sheet (annual, 2025-12-31) — Common Stock: 0.00
APO balance_sheet (quarterly, 2025-12-31) — Common Stock: 0.00
APO cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -1201000000.00
APO cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -311000000.00
APO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 21943000000.00
APO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 21943000000.00
APO cash_flow (annual, 2025-12-31) — Common Stock Payments: -773000000.00
APO cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -240000000.00
APO income_statement (annual, 2025-12-31) — Cost Of Revenue: 1443000000.00
APO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 411000000.00
APO balance_sheet (annual, 2025-12-31) — Current Assets: 260356000000.00
APO balance_sheet (quarterly, 2025-12-31) — Current Assets: 260356000000.00
APO balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 315889000000.00
APO balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 315889000000.00
APO balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 315889000000.00
APO balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 315889000000.00
APO balance_sheet (annual, 2025-12-31) — Current Liabilities: 331897000000.00
APO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 331897000000.00
APO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 1431000000.00
APO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 391000000.00
APO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1431000000.00
APO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 391000000.00
APO income_statement (annual, 2025-12-31) — Diluted Average Shares: 593657223.00
APO income_statement (annual, 2025-12-31) — Diluted EPS: 5.54
APO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 2144000000.00
APO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 342000000.00
APO balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Current: 663000000.00
APO balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Current: 663000000.00
APO balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 1062000000.00
APO balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 1062000000.00
APO income_statement (annual, 2025-12-31) — EBIT: 7047000000.00
APO income_statement (quarterly, 2025-12-31) — EBIT: 1868000000.00
APO income_statement (annual, 2025-12-31) — EBITDA: 8478000000.00
APO income_statement (quarterly, 2025-12-31) — EBITDA: 2259000000.00
APO cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 5000000.00
APO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -8000000.00
APO cash_flow (annual, 2025-12-31) — End Cash Position: 20591000000.00
APO cash_flow (quarterly, 2025-12-31) — End Cash Position: 20591000000.00
APO balance_sheet (annual, 2025-12-31) — Financial Assets: 9190000000.00
APO balance_sheet (quarterly, 2025-12-31) — Financial Assets: 9190000000.00
APO cash_flow (annual, 2025-12-31) — Financing Cash Flow: 60200000000.00
APO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 8947000000.00
APO cash_flow (annual, 2025-12-31) — Free Cash Flow: 7246000000.00
APO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 4669000000.00
APO cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -4843000000.00
APO cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -970000000.00
APO income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 36000000.00
APO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -2000000.00
APO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -2645000000.00
APO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -2645000000.00
APO income_statement (annual, 2025-12-31) — General And Administrative Expense: 3096000000.00
APO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 933000000.00
APO balance_sheet (annual, 2025-12-31) — Goodwill: 5920000000.00
APO balance_sheet (quarterly, 2025-12-31) — Goodwill: 5920000000.00
APO balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 5920000000.00
APO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 5920000000.00
APO income_statement (annual, 2025-12-31) — Gross Profit: 30606000000.00
APO income_statement (quarterly, 2025-12-31) — Gross Profit: 9453000000.00
APO cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 590000000.00
APO cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 63000000.00
APO income_statement (annual, 2025-12-31) — Interest Expense: 370000000.00
APO income_statement (quarterly, 2025-12-31) — Interest Expense: 116000000.00
APO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 370000000.00
APO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 116000000.00
APO income_statement (annual, 2025-12-31) — Interest Income: 131000000.00
APO income_statement (quarterly, 2025-12-31) — Interest Income: 57000000.00
APO income_statement (annual, 2025-12-31) — Interest Income Non Operating: 131000000.00
APO income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 57000000.00
APO cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 994000000.00
APO cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 190000000.00
APO balance_sheet (annual, 2025-12-31) — Invested Capital: 35307000000.00
APO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 35307000000.00
APO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -63972000000.00
APO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -14218000000.00
APO balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 1088000000.00
APO balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 1088000000.00
APO balance_sheet (annual, 2025-12-31) — Investments And Advances: 157777000000.00
APO balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 157777000000.00
APO cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
APO cash_flow (annual, 2025-12-31) — Issuance Of Debt: 7218000000.00
APO cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 2516000000.00
APO balance_sheet (annual, 2025-12-31) — Long Term Debt: 13364000000.00
APO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 13364000000.00
APO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 13364000000.00
APO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 13364000000.00
APO cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 7218000000.00
APO cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 2516000000.00
APO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -4644000000.00
APO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -2445000000.00
APO balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 1278000000.00
APO balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 1278000000.00
APO balance_sheet (annual, 2025-12-31) — Minority Interest: 19174000000.00
APO balance_sheet (quarterly, 2025-12-31) — Minority Interest: 19174000000.00
APO income_statement (annual, 2025-12-31) — Minority Interests: -1909000000.00
APO income_statement (quarterly, 2025-12-31) — Minority Interests: -476000000.00
APO cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 83407000000.00
APO cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 27930000000.00
APO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -773000000.00
APO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -240000000.00
APO income_statement (annual, 2025-12-31) — Net Income: 3492000000.00
APO income_statement (quarterly, 2025-12-31) — Net Income: 684000000.00
APO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 2144000000.00
APO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 342000000.00
APO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 5401000000.00
APO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 1160000000.00
APO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 3492000000.00
APO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 684000000.00
APO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 3492000000.00
APO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 684000000.00
APO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 5401000000.00
APO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 1160000000.00
APO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 5401000000.00
APO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 1160000000.00
APO income_statement (annual, 2025-12-31) — Net Interest Income: -239000000.00
APO income_statement (quarterly, 2025-12-31) — Net Interest Income: -59000000.00
APO cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -145787000000.00
APO cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -40967000000.00
APO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 2574000000.00
APO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 71000000.00
APO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 2574000000.00
APO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 71000000.00
APO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -239000000.00
APO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -59000000.00
APO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 59697000000.00
APO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 9451000000.00
APO cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -1592000000.00
APO cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -1181000000.00
APO cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 0.00
APO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 17421000000.00
APO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 17421000000.00
APO balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 8634000000.00
APO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 8634000000.00
APO income_statement (annual, 2025-12-31) — Normalized EBITDA: 9684000000.00
APO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 2589000000.00
APO income_statement (annual, 2025-12-31) — Normalized Income: 4467654000.00
APO income_statement (quarterly, 2025-12-31) — Normalized Income: 902493150.68
APO cash_flow (annual, 2025-12-31) — Operating Cash Flow: 7246000000.00
APO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 4669000000.00
APO cash_flow (annual, 2025-12-31) — Operating Gains Losses: -4843000000.00
APO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -970000000.00
APO income_statement (annual, 2025-12-31) — Operating Income: 8258000000.00
APO income_statement (quarterly, 2025-12-31) — Operating Income: 2105000000.00
APO income_statement (annual, 2025-12-31) — Operating Revenue: 32024000000.00
APO income_statement (quarterly, 2025-12-31) — Operating Revenue: 9855000000.00
APO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 578981398.00
APO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 578981398.00
APO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -2645000000.00
APO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -2645000000.00
APO income_statement (annual, 2025-12-31) — Other Gand A: 1546000000.00
APO income_statement (quarterly, 2025-12-31) — Other Gand A: 459000000.00
APO income_statement (annual, 2025-12-31) — Other Income Expense: -1342000000.00
APO income_statement (quarterly, 2025-12-31) — Other Income Expense: -294000000.00
APO balance_sheet (annual, 2025-12-31) — Other Investments: 155411000000.00
APO balance_sheet (quarterly, 2025-12-31) — Other Investments: 155411000000.00
APO cash_flow (annual, 2025-12-31) — Other Non Cash Items: -1733000000.00
APO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 1617000000.00
APO balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 19072000000.00
APO balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 19072000000.00
APO balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 73173000000.00
APO balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 73173000000.00
APO income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -136000000.00
APO income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 36000000.00
APO income_statement (annual, 2025-12-31) — Other Operating Expenses: 19252000000.00
APO income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 6415000000.00
APO balance_sheet (annual, 2025-12-31) — Other Payable: 11085000000.00
APO balance_sheet (quarterly, 2025-12-31) — Other Payable: 11085000000.00
APO balance_sheet (annual, 2025-12-31) — Other Receivables: 10282000000.00
APO balance_sheet (quarterly, 2025-12-31) — Other Receivables: 10282000000.00
APO balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 228820000000.00
APO balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 228820000000.00
APO income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 1251000000.00
APO income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 318000000.00
APO balance_sheet (annual, 2025-12-31) — Payables: 16008000000.00
APO balance_sheet (quarterly, 2025-12-31) — Payables: 16008000000.00
APO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 16008000000.00
APO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 16008000000.00
APO balance_sheet (annual, 2025-12-31) — Preferred Shares Number: 28749665.00
APO balance_sheet (quarterly, 2025-12-31) — Preferred Shares Number: 28749665.00
APO balance_sheet (annual, 2025-12-31) — Preferred Stock: 1398000000.00
APO balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 1398000000.00
APO cash_flow (annual, 2025-12-31) — Preferred Stock Dividend Paid: -97000000.00
APO cash_flow (quarterly, 2025-12-31) — Preferred Stock Dividend Paid: -24000000.00
APO income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 97000000.00
APO income_statement (quarterly, 2025-12-31) — Preferred Stock Dividends: 24000000.00
APO balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 1398000000.00
APO balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 1398000000.00
APO cash_flow (annual, 2025-12-31) — Preferred Stock Issuance: 0.00
APO income_statement (annual, 2025-12-31) — Pretax Income: 6677000000.00
APO income_statement (quarterly, 2025-12-31) — Pretax Income: 1752000000.00
APO cash_flow (annual, 2025-12-31) — Purchase Of Business: -9198000000.00
APO cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -3207000000.00
APO cash_flow (annual, 2025-12-31) — Purchase Of Investment: -145787000000.00
APO cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -40967000000.00
APO balance_sheet (annual, 2025-12-31) — Receivables: 10945000000.00
APO balance_sheet (quarterly, 2025-12-31) — Receivables: 10945000000.00
APO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 1443000000.00
APO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 411000000.00
APO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1431000000.00
APO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 391000000.00
APO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -4644000000.00
APO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -2445000000.00
APO cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -773000000.00
APO cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -240000000.00
APO balance_sheet (annual, 2025-12-31) — Restricted Cash: 1351000000.00
APO balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 1351000000.00
APO income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 1242000000.00
APO income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 328000000.00
APO balance_sheet (annual, 2025-12-31) — Retained Earnings: 7634000000.00
APO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 7634000000.00
APO income_statement (annual, 2025-12-31) — Salaries And Wages: 1550000000.00
APO income_statement (quarterly, 2025-12-31) — Salaries And Wages: 474000000.00
APO cash_flow (annual, 2025-12-31) — Sale Of Business: 92605000000.00
APO cash_flow (quarterly, 2025-12-31) — Sale Of Business: 31137000000.00
APO income_statement (annual, 2025-12-31) — Selling General And Administration: 3096000000.00
APO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 933000000.00
APO balance_sheet (annual, 2025-12-31) — Share Issued: 578981398.00
APO balance_sheet (quarterly, 2025-12-31) — Share Issued: 578981398.00
APO income_statement (annual, 2025-12-31) — Special Income Charges: -1242000000.00
APO income_statement (quarterly, 2025-12-31) — Special Income Charges: -328000000.00
APO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 789000000.00
APO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 266000000.00
APO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 23341000000.00
APO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 23341000000.00
APO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 16023000000.00
APO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 16023000000.00
APO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -230346000.00
APO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -111506849.32
APO income_statement (annual, 2025-12-31) — Tax Provision: 1276000000.00
APO income_statement (quarterly, 2025-12-31) — Tax Provision: 592000000.00
APO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.19
APO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.34
APO balance_sheet (annual, 2025-12-31) — Total Assets: 460949000000.00
APO balance_sheet (quarterly, 2025-12-31) — Total Assets: 460949000000.00
APO balance_sheet (annual, 2025-12-31) — Total Capitalization: 36705000000.00
APO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 36705000000.00
APO balance_sheet (annual, 2025-12-31) — Total Debt: 13364000000.00
APO balance_sheet (quarterly, 2025-12-31) — Total Debt: 13364000000.00
APO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 42515000000.00
APO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 42515000000.00
APO income_statement (annual, 2025-12-31) — Total Expenses: 23791000000.00
APO income_statement (quarterly, 2025-12-31) — Total Expenses: 7759000000.00
APO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 418434000000.00
APO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 418434000000.00
APO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 200593000000.00
APO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 200593000000.00
APO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 86537000000.00
APO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 86537000000.00
APO income_statement (annual, 2025-12-31) — Total Unusual Items: -1206000000.00
APO income_statement (quarterly, 2025-12-31) — Total Unusual Items: -330000000.00
APO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -1206000000.00
APO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -330000000.00
APO balance_sheet (annual, 2025-12-31) — Working Capital: -71541000000.00
APO balance_sheet (quarterly, 2025-12-31) — Working Capital: -71541000000.00
APO income_statement (quarterly, 2026-03-31) — +Operating Expense: 3850000000.00
APO income_statement (quarterly, 2026-03-31) — +Total Revenue: 5057000000.00
APO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 3857000000.00
APO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 16540000000.00
APO balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 763000000.00
APO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 595000000.00
APO income_statement (quarterly, 2026-03-31) — Basic EPS: -3.27
APO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 20591000000.00
APO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1398000000.00
APO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 22570000000.00
APO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 253184000000.00
APO cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -336000000.00
APO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 9872000000.00
APO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -8334000000.00
APO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 1620000000.00
APO cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -259000000.00
APO cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 1839000000.00
APO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 1580000000.00
APO cash_flow (quarterly, 2026-03-31) — Changes In Cash: 3158000000.00
APO balance_sheet (quarterly, 2026-03-31) — Common Stock: 0.00
APO cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -312000000.00
APO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 18553000000.00
APO cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -632000000.00
APO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 413000000.00
APO balance_sheet (quarterly, 2026-03-31) — Current Assets: 265527000000.00
APO balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 326502000000.00
APO balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 326502000000.00
APO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 340184000000.00
APO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 397000000.00
APO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 397000000.00
APO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 595000000.00
APO income_statement (quarterly, 2026-03-31) — Diluted EPS: -3.27
APO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -2242000000.00
APO balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Current: 861000000.00
APO balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Current: 1296000000.00
APO income_statement (quarterly, 2026-03-31) — EBIT: 418000000.00
APO income_statement (quarterly, 2026-03-31) — EBITDA: 815000000.00
APO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -1000000.00
APO cash_flow (quarterly, 2026-03-31) — End Cash Position: 23748000000.00
APO balance_sheet (quarterly, 2026-03-31) — Financial Assets: 8352000000.00
APO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 9872000000.00
APO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 1620000000.00
APO cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 1463000000.00
APO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -162000000.00
APO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -3144000000.00
APO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 737000000.00
APO balance_sheet (quarterly, 2026-03-31) — Goodwill: 5912000000.00
APO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 5912000000.00
APO income_statement (quarterly, 2026-03-31) — Gross Profit: 4644000000.00
APO income_statement (quarterly, 2026-03-31) — Interest Expense: 135000000.00
APO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 135000000.00
APO income_statement (quarterly, 2026-03-31) — Interest Income: 55000000.00
APO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 55000000.00
APO cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 220000000.00
APO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 32773000000.00
APO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -8334000000.00
APO balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 763000000.00
APO balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 160361000000.00
APO cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 3146000000.00
APO balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 14220000000.00
APO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 14220000000.00
APO cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 3146000000.00
APO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -1419000000.00
APO balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 1329000000.00
APO balance_sheet (quarterly, 2026-03-31) — Minority Interest: 19582000000.00
APO income_statement (quarterly, 2026-03-31) — Minority Interests: -495000000.00
APO cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 20090000000.00
APO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -632000000.00
APO income_statement (quarterly, 2026-03-31) — Net Income: -1906000000.00
APO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -2242000000.00
APO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -1411000000.00
APO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -1906000000.00
APO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -1906000000.00
APO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -1411000000.00
APO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -1411000000.00
APO income_statement (quarterly, 2026-03-31) — Net Interest Income: -42000000.00
APO cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -28698000000.00
APO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 1727000000.00
APO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 1727000000.00
APO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -42000000.00
APO cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 9113000000.00
APO cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 274000000.00
APO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 14039000000.00
APO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 8812000000.00
APO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 1314000000.00
APO income_statement (quarterly, 2026-03-31) — Normalized Income: -1606600000.00
APO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 1620000000.00
APO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 1463000000.00
APO income_statement (quarterly, 2026-03-31) — Operating Income: 794000000.00
APO income_statement (quarterly, 2026-03-31) — Operating Revenue: 5053000000.00
APO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 576507457.00
APO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -3144000000.00
APO income_statement (quarterly, 2026-03-31) — Other Gand A: 439000000.00
APO income_statement (quarterly, 2026-03-31) — Other Income Expense: -469000000.00
APO balance_sheet (quarterly, 2026-03-31) — Other Investments: 158269000000.00
APO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -641000000.00
APO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 18566000000.00
APO balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 73593000000.00
APO income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 30000000.00
APO income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 3115000000.00
APO balance_sheet (quarterly, 2026-03-31) — Other Payable: 8529000000.00
APO balance_sheet (quarterly, 2026-03-31) — Other Receivables: 10304000000.00
APO balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 230614000000.00
APO income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 312000000.00
APO balance_sheet (quarterly, 2026-03-31) — Payables: 13682000000.00
APO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 13682000000.00
APO balance_sheet (quarterly, 2026-03-31) — Preferred Shares Number: 28749665.00
APO balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 1398000000.00
APO cash_flow (quarterly, 2026-03-31) — Preferred Stock Dividend Paid: -24000000.00
APO income_statement (quarterly, 2026-03-31) — Preferred Stock Dividends: 24000000.00
APO balance_sheet (quarterly, 2026-03-31) — Preferred Stock Equity: 1398000000.00
APO income_statement (quarterly, 2026-03-31) — Pretax Income: 283000000.00
APO income_statement (quarterly, 2026-03-31) — Provision For Doubtful Accounts: -2000000.00
APO cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -2497000000.00
APO cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -28698000000.00
APO balance_sheet (quarterly, 2026-03-31) — Receivables: 11165000000.00
APO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 413000000.00
APO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 397000000.00
APO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -1419000000.00
APO cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -632000000.00
APO balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 1178000000.00
APO income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 337000000.00
APO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 5157000000.00
APO income_statement (quarterly, 2026-03-31) — Salaries And Wages: 298000000.00
APO cash_flow (quarterly, 2026-03-31) — Sale Of Business: 22587000000.00
APO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 737000000.00
APO balance_sheet (quarterly, 2026-03-31) — Share Issued: 576507457.00
APO income_statement (quarterly, 2026-03-31) — Special Income Charges: -337000000.00
APO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 232000000.00
APO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 19951000000.00
APO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 12641000000.00
APO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -199600000.00
APO income_statement (quarterly, 2026-03-31) — Tax Provision: 1694000000.00
APO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
APO balance_sheet (quarterly, 2026-03-31) — Total Assets: 467530000000.00
APO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 34171000000.00
APO balance_sheet (quarterly, 2026-03-31) — Total Debt: 14220000000.00
APO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 39533000000.00
APO income_statement (quarterly, 2026-03-31) — Total Expenses: 4263000000.00
APO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 427997000000.00
APO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 202003000000.00
APO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 87813000000.00
APO income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: -38000000.00
APO income_statement (quarterly, 2026-03-31) — Total Unusual Items: -499000000.00
APO income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -499000000.00
APO balance_sheet (quarterly, 2026-03-31) — Working Capital: -74657000000.00
APOG balance_sheet (annual, 2022-02-28) — Current Accrued Expenses: 50977000.00
APOG balance_sheet (annual, 2022-02-28) — Current Debt: 1000000.00
APOG balance_sheet (annual, 2022-02-28) — Current Deferred Assets: 30403000.00
APOG cash_flow (annual, 2022-02-28) — Gain Loss On Sale Of PPE: -20987000.00
APOG income_statement (annual, 2022-02-28) — Impairment Of Capital Assets: 49473000.00
APOG balance_sheet (annual, 2022-02-28) — Income Tax Payable: 15770000.00
APOG cash_flow (annual, 2022-02-28) — Net Short Term Debt Issuance: 0.00
APOG cash_flow (annual, 2022-02-28) — Operating Gains Losses: -20987000.00
APOG balance_sheet (annual, 2022-02-28) — Other Current Borrowings: 1000000.00
APOG cash_flow (annual, 2022-02-28) — Proceeds From Stock Option Exercised: 4115000.00
APOG balance_sheet (annual, 2022-02-28) — Receivables Adjustments Allowances: -2132000.00
APOG balance_sheet (annual, 2022-02-28) — Restricted Cash: 0.00
APOG cash_flow (annual, 2022-02-28) — Short Term Debt Issuance: 0.00
APOG cash_flow (annual, 2022-02-28) — Short Term Debt Payments: 0.00
APOG income_statement (annual, 2022-02-28) — Special Income Charges: -49473000.00
APOG income_statement (annual, 2022-02-28) — Total Unusual Items: -49473000.00
APOG income_statement (annual, 2022-02-28) — Total Unusual Items Excluding Goodwill: -49473000.00
APOG income_statement (annual, 2023-02-28) — +Operating Expense: 209485000.00
APOG income_statement (annual, 2023-02-28) — +Total Revenue: 1440696000.00
APOG balance_sheet (annual, 2023-02-28) — Accounts Payable: 86549000.00
APOG balance_sheet (annual, 2023-02-28) — Accounts Receivable: 197267000.00
APOG balance_sheet (annual, 2023-02-28) — Accumulated Depreciation: -431710000.00
APOG balance_sheet (annual, 2023-02-28) — Additional Paid In Capital: 146816000.00
APOG cash_flow (annual, 2023-02-28) — Asset Impairment Charge: 0.00
APOG income_statement (annual, 2023-02-28) — Basic Average Shares: 22007000.00
APOG income_statement (annual, 2023-02-28) — Basic EPS: 4.73
APOG cash_flow (annual, 2023-02-28) — Beginning Cash Position: 37583000.00
APOG balance_sheet (annual, 2023-02-28) — Buildings And Improvements: 188949000.00
APOG cash_flow (annual, 2023-02-28) — Capital Expenditure: -45177000.00
APOG cash_flow (annual, 2023-02-28) — Capital Expenditure Reported: -45177000.00
APOG balance_sheet (annual, 2023-02-28) — Capital Lease Obligations: 44878000.00
APOG balance_sheet (annual, 2023-02-28) — Capital Stock: 7408000.00
APOG balance_sheet (annual, 2023-02-28) — Cash And Cash Equivalents: 19924000.00
APOG balance_sheet (annual, 2023-02-28) — Cash Cash Equivalents And Short Term Investments: 19924000.00
APOG cash_flow (annual, 2023-02-28) — Cash Dividends Paid: -19670000.00
APOG cash_flow (annual, 2023-02-28) — Cash Flow From Continuing Financing Activities: -91023000.00
APOG cash_flow (annual, 2023-02-28) — Cash Flow From Continuing Investing Activities: -27710000.00
APOG cash_flow (annual, 2023-02-28) — Cash Flow From Continuing Operating Activities: 102696000.00
APOG cash_flow (annual, 2023-02-28) — Change In Account Payable: -5491000.00
APOG cash_flow (annual, 2023-02-28) — Change In Accrued Expense: -1810000.00
APOG cash_flow (annual, 2023-02-28) — Change In Inventory: 1731000.00
APOG cash_flow (annual, 2023-02-28) — Change In Other Current Liabilities: -12149000.00
APOG cash_flow (annual, 2023-02-28) — Change In Other Working Capital: 25789000.00
APOG cash_flow (annual, 2023-02-28) — Change In Payable: -5491000.00
APOG cash_flow (annual, 2023-02-28) — Change In Payables And Accrued Expense: -7301000.00
APOG cash_flow (annual, 2023-02-28) — Change In Receivables: -65684000.00
APOG cash_flow (annual, 2023-02-28) — Change In Working Capital: -57614000.00
APOG cash_flow (annual, 2023-02-28) — Changes In Account Receivables: -62304000.00
APOG cash_flow (annual, 2023-02-28) — Changes In Cash: -16037000.00
APOG balance_sheet (annual, 2023-02-28) — Common Stock: 7408000.00
APOG cash_flow (annual, 2023-02-28) — Common Stock Dividend Paid: -19670000.00
APOG balance_sheet (annual, 2023-02-28) — Common Stock Equity: 396408000.00
APOG cash_flow (annual, 2023-02-28) — Common Stock Payments: -74312000.00
APOG balance_sheet (annual, 2023-02-28) — Construction In Progress: 41842000.00
APOG income_statement (annual, 2023-02-28) — Cost Of Revenue: 1105423000.00
APOG balance_sheet (annual, 2023-02-28) — Current Accrued Expenses: 51651000.00
APOG balance_sheet (annual, 2023-02-28) — Current Assets: 383101000.00
APOG balance_sheet (annual, 2023-02-28) — Current Capital Lease Obligation: 11806000.00
APOG balance_sheet (annual, 2023-02-28) — Current Debt And Capital Lease Obligation: 11806000.00
APOG balance_sheet (annual, 2023-02-28) — Current Deferred Assets: 33569000.00
APOG balance_sheet (annual, 2023-02-28) — Current Deferred Liabilities: 28011000.00
APOG balance_sheet (annual, 2023-02-28) — Current Deferred Revenue: 28011000.00
APOG balance_sheet (annual, 2023-02-28) — Current Liabilities: 242549000.00
APOG balance_sheet (annual, 2023-02-28) — Current Provisions: 14447000.00
APOG cash_flow (annual, 2023-02-28) — Deferred Income Tax: -7185000.00
APOG cash_flow (annual, 2023-02-28) — Deferred Tax: -7185000.00
APOG cash_flow (annual, 2023-02-28) — Depreciation Amortization Depletion: 42403000.00
APOG cash_flow (annual, 2023-02-28) — Depreciation And Amortization: 42403000.00
APOG income_statement (annual, 2023-02-28) — Diluted Average Shares: 22416000.00
APOG income_statement (annual, 2023-02-28) — Diluted EPS: 4.64
APOG income_statement (annual, 2023-02-28) — Diluted NI Availto Com Stockholders: 104107000.00
APOG income_statement (annual, 2023-02-28) — EBIT: 124281000.00
APOG income_statement (annual, 2023-02-28) — EBITDA: 166684000.00
APOG cash_flow (annual, 2023-02-28) — Effect Of Exchange Rate Changes: -73000.00
APOG balance_sheet (annual, 2023-02-28) — Employee Benefits: 5749000.00
APOG cash_flow (annual, 2023-02-28) — End Cash Position: 21473000.00
APOG cash_flow (annual, 2023-02-28) — Financing Cash Flow: -91023000.00
APOG balance_sheet (annual, 2023-02-28) — Finished Goods: 23548000.00
APOG cash_flow (annual, 2023-02-28) — Free Cash Flow: 57519000.00
APOG cash_flow (annual, 2023-02-28) — Gain Loss On Sale Of PPE: -3815000.00
APOG balance_sheet (annual, 2023-02-28) — Gains Losses Not Affecting Retained Earnings: -31556000.00
APOG balance_sheet (annual, 2023-02-28) — Goodwill: 129026000.00
APOG balance_sheet (annual, 2023-02-28) — Goodwill And Other Intangible Assets: 196401000.00
APOG balance_sheet (annual, 2023-02-28) — Gross Accounts Receivable: 199063000.00
APOG balance_sheet (annual, 2023-02-28) — Gross PPE: 721931000.00
APOG income_statement (annual, 2023-02-28) — Gross Profit: 335273000.00
APOG income_statement (annual, 2023-02-28) — Impairment Of Capital Assets: 0.00
APOG balance_sheet (annual, 2023-02-28) — Income Tax Payable: 7129000.00
APOG income_statement (annual, 2023-02-28) — Interest Expense: 7660000.00
APOG income_statement (annual, 2023-02-28) — Interest Expense Non Operating: 7660000.00
APOG balance_sheet (annual, 2023-02-28) — Inventory: 78441000.00
APOG balance_sheet (annual, 2023-02-28) — Invested Capital: 566245000.00
APOG cash_flow (annual, 2023-02-28) — Investing Cash Flow: -27710000.00
APOG cash_flow (annual, 2023-02-28) — Issuance Of Debt: 485879000.00
APOG balance_sheet (annual, 2023-02-28) — Land And Improvements: 3600000.00
APOG balance_sheet (annual, 2023-02-28) — Long Term Capital Lease Obligation: 33072000.00
APOG balance_sheet (annual, 2023-02-28) — Long Term Debt: 169837000.00
APOG balance_sheet (annual, 2023-02-28) — Long Term Debt And Capital Lease Obligation: 202909000.00
APOG cash_flow (annual, 2023-02-28) — Long Term Debt Issuance: 485879000.00
APOG cash_flow (annual, 2023-02-28) — Long Term Debt Payments: -478865000.00
APOG balance_sheet (annual, 2023-02-28) — Long Term Provisions: 29316000.00
APOG balance_sheet (annual, 2023-02-28) — Machinery Furniture Equipment: 446186000.00
APOG cash_flow (annual, 2023-02-28) — Net Business Purchase And Sale: 0.00
APOG cash_flow (annual, 2023-02-28) — Net Common Stock Issuance: -74312000.00
APOG balance_sheet (annual, 2023-02-28) — Net Debt: 149913000.00
APOG income_statement (annual, 2023-02-28) — Net Income: 104107000.00
APOG income_statement (annual, 2023-02-28) — Net Income Common Stockholders: 104107000.00
APOG income_statement (annual, 2023-02-28) — Net Income Continuous Operations: 104107000.00
APOG income_statement (annual, 2023-02-28) — Net Income From Continuing And Discontinued Operation: 104107000.00
APOG income_statement (annual, 2023-02-28) — Net Income From Continuing Operation Net Minority Interest: 104107000.00
APOG cash_flow (annual, 2023-02-28) — Net Income From Continuing Operations: 104107000.00
APOG income_statement (annual, 2023-02-28) — Net Income Including Noncontrolling Interests: 104107000.00
APOG income_statement (annual, 2023-02-28) — Net Interest Income: -7660000.00
APOG cash_flow (annual, 2023-02-28) — Net Investment Purchase And Sale: 9712000.00
APOG cash_flow (annual, 2023-02-28) — Net Issuance Payments Of Debt: 7014000.00
APOG cash_flow (annual, 2023-02-28) — Net Long Term Debt Issuance: 7014000.00
APOG income_statement (annual, 2023-02-28) — Net Non Operating Interest Income Expense: -7660000.00
APOG cash_flow (annual, 2023-02-28) — Net Other Financing Charges: -4055000.00
APOG balance_sheet (annual, 2023-02-28) — Net PPE: 290221000.00
APOG cash_flow (annual, 2023-02-28) — Net PPE Purchase And Sale: 7755000.00
APOG cash_flow (annual, 2023-02-28) — Net Short Term Debt Issuance: 158014000.00
APOG balance_sheet (annual, 2023-02-28) — Net Tangible Assets: 200007000.00
APOG balance_sheet (annual, 2023-02-28) — Non Current Deferred Liabilities: 26596000.00
APOG balance_sheet (annual, 2023-02-28) — Non Current Deferred Revenue: 19602000.00
APOG balance_sheet (annual, 2023-02-28) — Non Current Deferred Taxes Liabilities: 1417000.00
APOG balance_sheet (annual, 2023-02-28) — Non Current Pension And Other Postretirement Benefit Plans: 5749000.00
APOG income_statement (annual, 2023-02-28) — Normalized EBITDA: 166684000.00
APOG income_statement (annual, 2023-02-28) — Normalized Income: 104107000.00
APOG cash_flow (annual, 2023-02-28) — Operating Cash Flow: 102696000.00
APOG cash_flow (annual, 2023-02-28) — Operating Gains Losses: -3815000.00
APOG income_statement (annual, 2023-02-28) — Operating Income: 125788000.00
APOG income_statement (annual, 2023-02-28) — Operating Revenue: 1440696000.00
APOG balance_sheet (annual, 2023-02-28) — Ordinary Shares Number: 22224299.00
APOG balance_sheet (annual, 2023-02-28) — Other Current Assets: 26517000.00
APOG balance_sheet (annual, 2023-02-28) — Other Current Liabilities: 42956000.00
APOG balance_sheet (annual, 2023-02-28) — Other Equity Adjustments: -31556000.00
APOG income_statement (annual, 2023-02-28) — Other Income Expense: -1507000.00
APOG balance_sheet (annual, 2023-02-28) — Other Intangible Assets: 67375000.00
APOG cash_flow (annual, 2023-02-28) — Other Non Cash Items: 16144000.00
APOG balance_sheet (annual, 2023-02-28) — Other Non Current Assets: 45642000.00
APOG balance_sheet (annual, 2023-02-28) — Other Non Current Liabilities: 11838000.00
APOG income_statement (annual, 2023-02-28) — Other Non Operating Income Expenses: -1507000.00
APOG balance_sheet (annual, 2023-02-28) — Other Properties: 41354000.00
APOG balance_sheet (annual, 2023-02-28) — Other Receivables: 59403000.00
APOG balance_sheet (annual, 2023-02-28) — Payables: 93678000.00
APOG balance_sheet (annual, 2023-02-28) — Payables And Accrued Expenses: 93678000.00
APOG balance_sheet (annual, 2023-02-28) — Pensionand Other Post Retirement Benefit Plans Current: 51651000.00
APOG balance_sheet (annual, 2023-02-28) — Preferred Stock: 0.00
APOG income_statement (annual, 2023-02-28) — Pretax Income: 116621000.00
APOG cash_flow (annual, 2023-02-28) — Proceeds From Stock Option Exercised: 0.00
APOG balance_sheet (annual, 2023-02-28) — Properties: 0.00
APOG cash_flow (annual, 2023-02-28) — Purchase Of Business: 0.00
APOG cash_flow (annual, 2023-02-28) — Purchase Of Investment: 0.00
APOG balance_sheet (annual, 2023-02-28) — Raw Materials: 36869000.00
APOG balance_sheet (annual, 2023-02-28) — Receivables: 256670000.00
APOG balance_sheet (annual, 2023-02-28) — Receivables Adjustments Allowances: -1796000.00
APOG income_statement (annual, 2023-02-28) — Reconciled Cost Of Revenue: 1105423000.00
APOG income_statement (annual, 2023-02-28) — Reconciled Depreciation: 42403000.00
APOG cash_flow (annual, 2023-02-28) — Repayment Of Debt: -478865000.00
APOG cash_flow (annual, 2023-02-28) — Repurchase Of Capital Stock: -74312000.00
APOG balance_sheet (annual, 2023-02-28) — Restricted Cash: 1549000.00
APOG balance_sheet (annual, 2023-02-28) — Retained Earnings: 273740000.00
APOG cash_flow (annual, 2023-02-28) — Sale Of Investment: 9712000.00
APOG cash_flow (annual, 2023-02-28) — Sale Of PPE: 7755000.00
APOG income_statement (annual, 2023-02-28) — Selling General And Administration: 209485000.00
APOG balance_sheet (annual, 2023-02-28) — Share Issued: 22224299.00
APOG cash_flow (annual, 2023-02-28) — Short Term Debt Issuance: 485879000.00
APOG cash_flow (annual, 2023-02-28) — Short Term Debt Payments: -327865000.00
APOG income_statement (annual, 2023-02-28) — Special Income Charges: 0.00
APOG cash_flow (annual, 2023-02-28) — Stock Based Compensation: 8656000.00
APOG balance_sheet (annual, 2023-02-28) — Stockholders Equity: 396408000.00
APOG balance_sheet (annual, 2023-02-28) — Tangible Book Value: 200007000.00